首页 › 基金 › Rosalind Advisors, Inc. › TENX

Rosalind Advisors, Inc. 对 TENX 的持仓历史

TENAX THERAPEUTICS INC · 医疗保健

Rosalind Advisors, Inc. 在 Q2 2026 的 13F 申报中披露持有 TENX(TENAX THERAPEUTICS INC)6,200 股,市值约 US$14K,约占其申报组合的 0.01%,在其申报持仓中市值排名第 33 位。 Rosalind Advisors, Inc. 于 Q2 2026 首次申报该持仓。

最新持仓 (Q2 2026)6.20K 股
申报持仓市值$13.95K
组合权重0.01%
首次申报Q2 2026
最近变动新进
更新于2026-10-24

最后更新: 2026-10-24 · 来源: SEC EDGAR Form 13F-HR

Rosalind Advisors, Inc. 对 TENX 的持仓演变

Rosalind Advisors, Inc. 于 Q2 2026 首次披露 TENX 持仓:6,200 股(约 US$14K)。

逐季持仓明细

季度股数金额变化
Q2 2026 6.20K $13.95K 新进

关于 TENX 与 13F 数据

TENX(TENAX THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 104 只申报持有 TENX,申报仓位最大的包括:Vivo Capital, LLC (US$36.4M), Stonepine Capital Management, LLC (US$9.6M), Sofinnova Investments, Inc. (US$7.3M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 TENX 的基金

查看 TENX 的全部基金持有人 →

常见问题

How long has Rosalind Advisors, Inc. held TENX?

Rosalind Advisors, Inc. has disclosed TENX holdings in 1 of the last 1 reported quarters, going back to Q2 2026.

What is Rosalind Advisors, Inc.'s current position in TENX?

As of Q2 2026, Rosalind Advisors, Inc. holds 6.20K shares of TENX (TENAX THERAPEUTICS INC), valued at $13.95K, representing 0.01% of its reported portfolio and ranking #33.

Has Rosalind Advisors, Inc. been buying or selling TENX?

In the latest 13F filing (Q2 2026), Rosalind Advisors, Inc. newly opened its position in TENX.

Which other funds hold TENX?

Other major institutional holders of TENX include Vivo Capital, LLC, Stonepine Capital Management, LLC, Sofinnova Investments, Inc., among 104 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.